Healing sounds and virtual worlds may replace sedatives in heart cath labs
NCT ID NCT07681180
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This pilot study explores whether non-drug strategies like virtual reality or relaxing soundscapes can reduce anxiety and pain in adults undergoing scheduled coronary angiography or angioplasty. Participants will be assigned to listen to calming sounds, experience a virtual reality environment, or receive standard care. The study measures changes in anxiety, pain, and the need for anxiety or pain medications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
virtual reality and relaxing soundscapes
What this could lead to
If effective, these non-drug approaches could offer a safer way to manage anxiety during heart procedures, reducing the need for sedatives.
What could go wrong
This is a small pilot study, so results may not apply to all patients. The interventions may not significantly lower anxiety or pain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Omega-3 for Type 2 Diabetes & Heart Disease - NCT07677995
- 4D MRI Study for Chronic Disease Prognosis (NCT07678606)
- Cardiovascular, Kidney & Metabolic Disease Study NCT07673822
- Cardiology Biobank Registry (NCT00378924)
- Prostate Cancer & Heart Health Study (NCT03127631)
- Barriers to Psychosocial Care in Cardiac Rehab | NCT07651501
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IUCPQ
Québec, Quebec, G1V 4G5, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact